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Phenylalanine Residues at the Carboxyl Terminus of the Herpes
Simplex Virus 1 UL20 Membrane Protein Regulate Cytoplasmic
Virion Envelopment and Infectious Virus Production
Anu-Susan Charles, Vladimir N. Chouljenko, Nithya Jambunathan, Ramesh Subramanian, Peter Mottram, Konstantin G. Kousoulas
Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge,
Louisiana, USA

ABSTRACT

IMPORTANCE

We have shown previously that the UL20/gK protein complex serves crucial roles in cytoplasmic virion envelopment and that it
interacts with the UL37 tegument protein to facilitate cytoplasmic virion envelopment. In this study, we investigated the role of
phenylalanine residues within the carboxyl terminus of UL20p, since aromatic and hydrophobic amino acids are known to be
involved in protein-protein interactions through stacking of their aromatic structures. Characterization of mutant viruses carrying phenylalanine (Phe)-to-alanine (Ala) mutations revealed that the two membrane-proximal Phe residues were critical for the
proper UL20p membrane topology and efficient virion envelopment and infectious virus production. Surprisingly, a Phe-to-Ala
change located approximately in the middle of the UL20p carboxyl terminus substantially enhanced cytoplasmic envelopment
and overall production of infectious virions. This work revealed that Phe residues within the UL20p carboxyl terminus are involved in the regulation of cytoplasmic virion envelopment and infectious virus production.

H

erpes simplex virus type 1 (HSV-1) is a neurotropic virus
that, after replication in epithelial cells, enters into ganglionic
neurons via distal axons and establishes latent infection (1–3).
HSV-1 is the primary infectious cause of blindness in the western
hemisphere, primarily because periodic reactivation causes recurrent keratitis and scarring of the cornea (4, 5). Herpesvirus particles consist of a linear double-stranded DNA genome containing
an icosahedral capsid, surrounded by a proteinaceous tegument
and, outermost, a cell-derived lipid envelope. The virus encodes at
least 12 glycosylated and several nonglycosylated proteins expressed on the viral envelope and in infected cell membranes that
are important for the life cycle of the virus, especially during virus
entry, intracellular virion morphogenesis, and cell-to-cell spread.
HSV-1 virion morphogenesis and egress involves complex mechanisms, which are characterized by sequential morphogenetic
steps, including (i) primary envelopment of capsids at the inner
nuclear membrane, (ii) de-envelopment of enveloped capsids at
the outer nuclear membrane, (iii) acquisition of tegument proteins in the cytoplasm of infected cells, and (iv) re-envelopment of
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tegumented capsids at the trans-Golgi network (TGN)-derived
membranes (6–8). Cytoplasmic virion envelopment is facilitated
by multiple interactions among viral glycoproteins embedded in
TGN membranes and tegument proteins (8–12).
The UL20 gene encodes a 222-amino-acid nonglycosylated envelope protein, which plays a crucial role in the cytoplasmic virion
envelopment and egress of HSV-1. The UL20 gene is highly conserved among alphaherpesviruses, including varicella-zoster virus
(13), pseudorabies virus (PRV) (14), and the gammaherpesvirus
Marek’s disease virus type 2 (15). The UL20 protein (UL20p) has
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The herpes simplex virus type 1 (HSV-1) UL20 gene encodes a 222-amino-acid nonglycosylated envelope protein which forms a
complex with viral glycoprotein K (gK) that functions in virion envelopment, egress, and virus-induced cell fusion. To investigate the role of the carboxyl terminus of the UL20 protein (UL20p) in cytoplasmic virion envelopment, a cadre of mutant viruses
was constructed and characterized. The deletion of six amino acids from the carboxyl terminus of UL20p caused an approximately 1-log reduction in infectious virus production compared to that of the wild-type virus. Surprisingly, a phenylalanine-toalanine replacement at amino acid position 210 caused a gain-of-function phenotype, increasing infectious virus production up
to 1 log more than in the wild-type virus. In contrast, the replacement of two membrane-proximal phenylalanines with alanines
caused drastic inhibition of infectious virion production and cytoplasmic virion envelopment. Prediction of the membrane topology of UL20p revealed that these two amino acid changes cause retraction of the carboxyl terminus of UL20p from the intracellular space. Confocal microscopy revealed that none of the engineered UL20 mutations affected intracellular transport of
UL20p to trans-Golgi network membranes. In addition, a proximity ligation assay showed that none of the UL20 mutations affected UL20p colocalization and potential interactions with the UL37 protein recently found to interact with the gK/UL20 protein complex. Collectively, these studies show that phenylalanine residues within the carboxyl terminus of UL20p are involved in
the regulation of cytoplasmic virion envelopment and infectious virus production.

Role of HSV-1 UL20 in Infectious Virus Production

MATERIALS AND METHODS
Cells. African green monkey kidney (Vero) cells were obtained from the
American Type Culture Collection (Rockville, MD), and the Vero-based
UL20 protein-complementing FRT cells (Flp-In-CV-1 cells derived from
the FLP recombination target [FRT] system) (30), were maintained in
Dulbecco’s modified Eagle’s medium (Gibco-BRL; Grand Island, NY)
supplemented with 10% fetal calf serum and antibiotics.
Construction of HSV-1 mutant viruses. Mutagenesis was accomplished in Escherichia coli cells using the markerless two-step Red recombination mutagenesis system and synthetic oligonucleotides (31, 32) implemented on the bacterial artificial chromosome (BAC) plasmid
pYEbac102-VC1 carrying the HSV-1(F) genome with gK and UL20 proteins tagged with V5 and 3⫻ FLAG antigenic epitopes, respectively. Unless otherwise specified, the wild-type virus used in all experiments is the
VC-1 strain. HSV-1 mutants UL20⌬Phe and UL20⌬6 were constructed
by adding a TAA stop codon in front of the last amino acid or the last 6
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TABLE 1 Names of mutants and amino acid sequences in the wild type
and mutants
Amino acid sequence in:
Mutanta

Wild type

Mutantb

UL20⌬Phe
UL20⌬6
UL20F222A
UL20F210A
UL20F205-206A

NAPVAF
RAILNA
NAPVAF
FFLARF
FFLARF

NAPVA*
RAIL*
NAPVAA
FFLARA
AALARF

a
b

Mutations are described in the text.
An asterisk indicates a stop codon.

amino acids, respectively, from the carboxyl end of UL20p. Mutants
UL20F222A, UL20F210A, and UL20F205-206A were created by changing
codons for phenylalanine (aromatic amino acid) to alanine (neutral
amino acid) at the positions indicated in the names (Table 1). HSV-1 BAC
DNAs were purified from 50 ml of overnight bacterial cultures with a
Qiagen large-construct kit (Qiagen; Valencia, CA). Using PCR test primers designed to lie outside the target mutation site(s), all mutated DNA
regions were sequenced to verify the presence of the desired mutations in
BACs. Similarly, viruses recovered from cells transfected with BACs (31)
were sequenced to confirm the presence of the desired mutations. The
entire genomes of the parental wild-type virus and the UL20F210A mutant viruses were sequenced using the Ion Torrent next-generation sequencing equipment (Life Technologies-Invitrogen; Carlsbad, CA), as we
described previously (33). Briefly, total genomic DNA (gDNA) was extracted from the virus-infected Vero cells using the PureLink genomic
DNA minikit (Life Technologies-Invitrogen; Carlsbad, CA). High-quality
fragment libraries of each virus were prepared from the extracted total
gDNAs using the Ion Xpress plus fragment library kit (Life TechnologiesInvitrogen; Carlsbad, CA). The fragment libraries were subsequently applied to Ion 316 chips and were sequenced on the Ion Personal Genome
Machine system (Life Technologies-Invitrogen; Carlsbad, CA).
SDS-PAGE and Western immunoblot assay. Western immunoblot
analysis was carried out essentially as described previously (34). Confluent
monolayers of Vero cells were infected with the indicated viruses at a
multiplicity of infection (MOI)/cell of 2. At 24 h postinfection (h.p.i.),
cells were washed with PBS and lysed on ice for 30 min in NP-40 lysis
buffer (Life Technologies) supplemented with a cocktail of protease inhibitors (Roche, LLC, Basel, Switzerland). The collected samples were
mixed with SDS-PAGE sample buffer (NuPAGE) at a 3:1 ratio and were
electrophoretically separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (4-to-20% gradient Tris-HEPES-SDS gels; Thermo
Scientific). Following electrophoresis, the proteins were transferred onto
a nitrocellulose membrane under a constant current. The membrane was
blocked in phosphate-buffered saline (PBS) containing 0.1% Tween 20
(PBST) plus 5% nonfat milk for 1 h at room temperature and was probed
with primary mouse anti-FLAG monoclonal antibodies (Abcam; Cambridge, England) at 4°C overnight. Goat anti-mouse secondary antibody
conjugated with horseradish peroxidase (HRP) and Immobilon chemiluminescent HRP substrate (Millipore) were used for detection purposes.
Plaque morphologies, replication kinetics, and electron microscopy. For plaque morphology experiments, confluent monolayers of Vero
or FRT cells were infected with the viruses at an MOI/cell of 0.001 and
fixed with methanol 48 h.p.i. Immunohistochemistry was performed with
primary rabbit anti-HSV antibodies (1:1,000) (Dako) and goat anti-rabbit
HRP-labeled antibody (1:1,000) (Dako), and the reactions were developed using the NovaRed substrate (Vector Laboratories). Images were
taken with an inverted light microscope (Olympus) using relief contrast.
Growth kinetics studies of viruses were performed as we described previously (35, 36). Approximately 90% confluent Vero cells were infected
with each virus at 4°C for 1 h at a low or high MOI/cell of 0.2 or 2,
respectively. Afterwards, plates were incubated at 37°C for 1 h to allow
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been shown to be important for infectious virion production for
both PRV and HSV-1 (16, 17). The UL20 protein forms a functional complex with glycoprotein K (gK), which physically binds
with gB and gH to modulate virus-induced cell fusion (18).
Previous studies in our laboratory showed that the deletion of
18 amino acids from the carboxyl terminus of UL20p (UL20 mutant virus 204t) inhibited the intracellular transport and cell surface expression of both gK and UL20p and, also, failed to complement infectious virus production. However, the deletion of either
6 (UL20 216t) or 11 amino acids (UL20 211t) allowed efficient
intracellular transport and cell surface expression of both gK and
UL20p but failed to complement for infectious virus production
(19). Phenylalanine residues are aromatic and hydrophobic
amino acids that are known to be involved in protein-protein
interactions and have been shown to play an important role in
respiratory syncytial virus assembly (20). Therefore, we sought to
determine the potential role of phenylalanine residues in the carboxyl terminus of UL20p in cytoplasmic virion envelopment and
egress, under the hypothesis that cytoplasmic domains of UL20p
may interact with tegument proteins to facilitate cytoplasmic virion envelopment. The UL37 protein is a 120-kDa phosphorylated protein (21) that assumes a predominantly diffuse cytoplasmic distribution in infected cells (22–24) and can be transported
to TGN membranes as a complex with the UL36 protein in the
absence of capsid formation (25). The UL37 tegument protein
specified by HSV-1 and PRV has been shown to play an important
role in cytoplasmic virion envelopment, since deletion of the
UL37 gene resulted in the accumulation of capsids in the cytoplasm of infected cells (26–28). Recently, we showed that the
HSV-1 UL37 protein interacts with gK and UL20p to facilitate
cytoplasmic virion envelopment (29).
Here, we show that a UL20 phenylalanine residue at position
210 plays a critical regulatory function in cytoplasmic virion envelopment and infectious virus production, as evidenced by the
surprisingly high infectious virus production of the mutant virus
containing a Phe-to-Ala substitution at amino acid residue 210,
which was 1 log higher than that of wild-type virus. Moreover, two
other phenylalanine residues proximal to the membrane of the
carboxyl terminus of UL20p are required for proper UL20p membrane topography and function. These phenylalanine-to-alanine
mutations did not appreciably alter the colocalization and potential interactions with the UL37 protein, suggesting that they do not
play major roles in the overall interactions between the UL37 protein and the gK/UL20 protein complex.

Charles et al.

virus penetration. Any remaining extracellular viruses were inactivated by
low-pH treatment using PBS at pH 3, plates were incubated, and infected
cells were collected at different time points and stored at 80°C. Viral titers
were obtained on FRT cells. The ultrastructural morphology of virions
within infected cells was examined by transmission electron microscopy
as described previously (18, 31, 35, 37). All flasks with infected cells were
incubated at 37°C and 5% CO2 until being processed at 18 h.p.i., and
infected cell samples were visualized by transmission electron microscopy.
Quantification of cell-to-cell fusion. A chemiluminescence-based assay system was used to quantify cellular fusion during viral infection (38–
40). Around 80 to 90% confluent Vero cells in 12-well plates were transfected separately with plasmids expressing the T7 polymerase gene or the
luciferase gene under the T7 promoter at amounts of 1 g/well each.

Lipofectamine 2000 (Invitrogen) was used for all transfections. The medium was changed 6 h posttransfection, and after 12 h of incubation at
37°C and 5% CO2, cells were detached using trypsin-EDTA. Both populations of cells were washed, further resuspended in complete medium,
and mixed in a 1:1 ratio prior to seeding in a 24-well plate. Fifteen hours
after seeding, the cells were infected at an MOI/cell of 0.5. At 24 h.p.i., the
cells were washed with PBS and lysed with lysis buffer and supernatants
were collected. The supernatant was mixed with luciferase assay substrate,
and the relative amounts of fusion were obtained by measuring the relative levels of luminescence (relative light units [RLU]) emitted using a
TD-20/20 luminometer (Turner Designs).
Quantitative PCR. Quantitative PCR (qPCR) was utilized to derive
the total number of viral genomes within the lysate. Specifically, the primers and probe (6-carboxytetramethylrhodamine [TAMRA]) for the real-

FIG 2 Plaque morphologies of mutant and parental wild-type viruses on Vero (a) or FRT cells (b). Confluent monolayers of Vero cells and FRT cells were
infected with an MOI/cell of 0.001 of wild-type and mutant viruses, and viral plaques were detected by immunohistochemistry using polyclonal anti-HSV rabbit
antisera at 48 h.p.i., as described in Materials and Methods.
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FIG 1 Predicted membrane topology of UL20p and locations of mutations. The amino acid position(s) of the amino acid(s) replacements are indicated, flanked
on the left by the targeted phenylalanine(s) and on the right by the changed alanine(s), e.g., UL20F222A. TM, transmembrane region.

Role of HSV-1 UL20 in Infectious Virus Production

FIG 4 Western immunoblots of UL20 protein (FLAG epitope) in lysates from

time PCR were designed to detect HSV-1 US6 (gD). Lysates were collected
at 18 h.p.i., and 200 l of each suspension was used for the extraction of
viral DNA. Viral DNA was extracted using a DNeasy blood and tissue kit
(Qiagen, Inc.) according to the manufacturer’s instructions. Equal volumes of viral DNA were used for TaqMan PCR analysis. Purified HSV-1
bacterial artificial chromosome (YE102) DNA was used to generate the
standard curve.
Confocal microscopy. Vero cell monolayers grown on an 8-well glass
Lab-Tek II chamber slide were infected with the viruses at an MOI/cell of
10. Uninfected cells were used as negative controls. Cells were washed
once with PBS and fixed with ice-cold 100% methanol for 10 min at 18
h.p.i. Monolayers were subsequently blocked for 1 h with 2% fetal calf
serum in PBS. Further staining was done using mouse monoclonal antiFLAG IgG1 (Sigma-Aldrich, St. Louis, MO) for recognition of UL20p and
TGOLN2 IgG2a (Abnova, Taiwan) for recognition of trans-Golgi network, diluted 1:200 in PBS blocking buffer, followed by Alexa Fluor 555conjugated goat anti-mouse IgG1 and Alexa Fluor 488-conjugated goat
anti-mouse IgG2a secondary antibodies. The nucleus was stained using
4=,6-diamidino-2-phenylindole (DAPI). Specific immunofluorescence
was examined using an Olympus FluoView confocal microscope. Image
analysis and subcellular scatter plot graphs were generated and analyzed
using the Olympus Fluoview FV1000 confocal microscope software interface. Scatterplot graphs with colocalization of two fluorophores within the
TGN were generated by specifically defining the regions of interest with a
bounding box of equal area based on pixel enumeration for each captured
image. To determine an approximate percentage of subcellular colocalization, pixel enumeration and intensity statistics within the Olympus
software package were accumulated for each sample image. The percentage of upper-right-quadrant pixels from the total pixels per sample was
displayed. Finally, the images were compiled and rendered with Adobe
Photoshop.
PLA. The in situ proximity ligation assay (PLA) for proximity ligation
reaction detection was carried out using the appropriate Duolink II In Situ
kit components obtained from Sigma-Aldrich, St. Louis, MO. Vero cell
monolayers grown on an 8-well glass Lab-Tek II chamber slide were infected with the viruses at an MOI/cell of 10. At 18 h.p.i., the cells were fixed
by using methanol for 10 min and blocked using Duolink blocking solution at 37°C in a wet chamber for 2 h. The primary antibodies used were
anti-FLAG mouse antibody (Sigma-Aldrich, St. Louis, MO) and antiUL37 rabbit antibody for the negative controls (mock infection and untagged wild-type F strain) and for the parental wild type, as well as the
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mutants. The primary antibodies used for the positive control (gK-UL20p
interaction) were anti-V5 mouse antibody (Invitrogen Life Technologies)
and anti-FLAG rabbit antibody (Sigma-Aldrich, St. Louis, MO). Antibodies were diluted in blocking buffer and incubated in a wet chamber at 4°C
overnight. The slides were washed two times with 1⫻ TBS plus 0.05%
Tween 20 for 5 min each, and then secondary antibodies (Duolink In Situ
PLA probe anti-rabbit plus and Duolink In Situ PLA probe anti-mouse
minus) were added and incubated at 37°C for 1 h. Two washes with
Duolink In Situ wash buffer A for 5 min each were then followed by the
addition of the ligation mixture and incubation in a wet chamber at 37°C
for 30 min. After ligation, the slides were washed twice for 2 min using
Duolink In Situ wash buffer A before adding amplification reaction mixture for 90 min at 37°C. Texas red-labeled oligonucleotide detection
probes (Olink Bioscience) were used. Subsequently, the slides were
washed twice with Duolink In Situ wash buffer B and once with 0.1⫻
Duolink In Situ wash buffer B. The slides were mounted with Duolink In
Situ mounting medium with DAPI and analyzed in an Olympus FluoView
confocal microscope.

RESULTS

Construction and molecular analysis of recombinant viruses.
We have shown previously that deletion of the UL20p carboxylterminal six amino acids results in drastic inhibition of cytoplasmic virion envelopment and egress (19). To further investigate the
potential role of phenylalanine residues within the carboxyl terminus of the UL20 protein, we constructed a cadre of mutant
viruses in which one or more phenylalanine residues were replaced with alanine residues. All mutant viruses were constructed
using the markerless two-step Red recombination mutagenesis
system implemented on the bacterial artificial chromosome
(BAC) plasmid pYEbac102-VC1 carrying the HSV-1(F) genome
(see Materials and Methods). This virus expresses gK and UL20p
tagged with V5 and 3⫻ FLAG antigenic epitopes, respectively (33,
41). The recombinant mutants included viruses having a deletion
of the terminal phenylalanine residue (UL20⌬Phe), deletion of six
amino acids from the carboxyl terminus (UL20⌬6), and replacement of one or two internal phenylalanine residues with alanines
(UL20F222A, UL20F210A, and UL20F205-206A) (Fig. 1 and Table 1). The deletion mutants were made by the insertion of stop
codon TAA in front of the last amino acid for UL20⌬Phe and
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FIG 3 The fusion activity of each virus was quantified by luciferase-based
assay (see Materials and Methods). The extent of fusion was assessed at 24
h.p.i. for the wild-type virus and all mutant viruses. Relative luciferase activity
readouts are shown, and error bars indicate the standard errors. gBsyn,
gB⌬28syn virus.

cells infected with the indicated viruses. Confluent monolayers of Vero cells
were infected with the viruses at an MOI/cell of 2. At 24 h.p.i., cell lysates were
collected, run on SDS-PAGE gels, and probed with anti-FLAG antibody.
Lanes: 1, Vero cell lysate; 2, parental wild-type lysate; 3, UL20⌬6 lysate; 4,
UL20⌬Phe lysate; 5, UL20F222A lysate; 6, UL20F210A lysate; 7, UL20F205206A lysate. Molecular weights (in thousands) are shown at the left.

Charles et al.

FIG 5 Replication kinetics of the parental wild-type and mutant viruses. Confluent Vero cell monolayers were infected with each virus at either a low MOI/cell

before the last 6 amino acids for UL20⌬6. Similarly, for the amino
acid replacement mutants, codons for phenylalanine (TTT or
TTC) were replaced with the codon for alanine (GCA). Virus
stocks were prepared after BAC transfection on FRT cells. Mutant
viral genomes were characterized using PCR-assisted DNA sequencing, as well as whole-genome sequencing (see Materials and
Methods).
Characterization of the ability of UL20 mutant viruses to
cause virus-induced cell fusion. The plaque morphologies of all
mutant and parental wild-type viruses were examined on Vero
cells (Fig. 2a) and FRT cells (Fig. 2b). As expected, the HSV1(VC-1) wild-type virus produced the largest virus plaques, while
the UL20F205-206A and UL20⌬6 viruses produced smaller viral
plaques than the parental wild-type virus on Vero cells. The recombinant viruses UL20⌬Phe and UL20F222A produced syncytial plaques on Vero cells (Fig. 2a). All mutants produced wildtype-like plaques on FRT cells (Vero cells transformed to express
the UL20 gene) (Fig. 2b). The extent of virus-induced cell fusion
was evaluated using a previously described luciferase assay (see
Materials and Methods) (33). The gB⌬28syn mutant HSV-1 virus,
which carries a 28-amino-acid deletion of the carboxyl terminus
of gB, causes extensive virus-induced cell fusion (34) and was used
as a positive control. The relative levels of luminescence were measured for all samples at 24 h h.p.i. Among the mutant viruses, the
UL20F222A virus produced the highest extent of fusion, exhibiting RFU levels similar to those of the positive-control gB⌬28syn
virus (Fig. 3).
UL20 protein expression and replication kinetics of mutant
viruses. Western immunoblot analysis revealed that all viruses
expressed similar levels of the UL20 protein (Fig. 4). To investigate
the role of these mutations in the kinetics of viral replication,
replication curves were produced for infections at both a low
(MOI/cell of 0.2) (Fig. 5a) and a high (MOI/cell of 2) (Fig. 5b)
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MOI/cell. At both the high and the low MOI/cell, the UL20F205206A mutant yielded the lowest end titer and the UL20F210A
mutant yielded the highest end titer compared to the end titer of
the parental wild-type virus. Importantly, the UL20F210A virus
reproducibly produced viral titers approximately 1 log higher
than that of the parental wild-type virus at the high MOI. At the
low MOI/cell of 0.2, the terminal viral titers of UL20⌬6 and
UL20F205-206A were 1 and 2 logs less than the parental wild-type
terminal titer, respectively, while the UL20F210A mutant virus produced significantly higher viral titers than the parental wild-type virus. At the MOI/cell of 2, the UL20F205-206A mutant virus titer was
more than 1 log less than the parental wild-type virus titer.
Ultrastructural characterization of parental wild-type and
mutant viruses. The ultrastructural phenotypes of all recombinant viruses were compared to that of the wild-type parental virus
after infection of Vero cells at an MOI/cell of 3 at 18 h.p.i. (Fig. 6).
As expected, the parental wild-type virus did not exhibit any defects in cytoplasmic virion envelopment and egress, as fully enveloped viruses were readily seen outside the infected cells via electron microscopy. In contrast, mutant viruses exhibited various
degrees of cytoplasmic defects in virion envelopment, as evidenced by the presence of numerous unenveloped or partially
enveloped capsids in the cytoplasm of infected cells (Fig. 6).
Characterization of the relative efficiencies of cytoplasmic
virion envelopment. A measure of the relative efficiencies of infectious virion production is indicated by the ratio of total viral
genomes produced in infected cells to the number of infectious
virions determined by the standard plaque assay. In this regard,
The UL20F205-206A mutation caused the most severe defect in
the relative efficiency of infectious virion production, followed
by the UL20⌬6 mutation (Table 2).
Intracellular localization of the UL20 mutant proteins and
UL20 interactions with the UL37 protein. The intracellular lo-
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(0.2) (a) or a high MOI/cell (2.0) (b), and viral titers were obtained by plaque assay on FRT cells at different time points postinfection. HPI, h postinfection; error
bars represent standard errors.

FIG 6 Ultrastructural morphologies of parental wild-type and mutant viruses. Electron micrographs of Vero cells infected with different viruses at an MOI/cell
of 3 and processed for electron microscopy at 18 h.p.i. are shown. The extracellular space (e) and cytoplasm (c) are marked. Arrows show viral particles with
envelopment defect, magnified in insets.

cation of parental wild-type and mutant UL20 proteins was
investigated using confocal microscopy. All mutant viruses expressed UL20p that colocalized with the TGN marker, which
was monoclonal antibody against trans-Golgi network protein
2 (TGOLN2). These observations were further supported by determination of the approximate percentage of subcellular colocalization using pixel enumeration and intensity statistics as detailed
in Materials and Methods (Fig. 7). Recently, we showed that the
UL37 protein physically interacted with the gK/UL20 protein
complex to facilitate cytoplasmic virion envelopment. To investiTABLE 2 Determination of HSV-1 genome-to-PFU ratios
Virus

Total no. of
genomes/PFUa

Wild type
UL20⌬6
UL20⌬Phe
UL20F222A
UL20F210A
UL20F205-206A

48,000
538,000
170,000
166,000
38,000
5,648,000

a
The total number of viral genomes in infected Vero cells at 24 h.p.i. was obtained by
qPCR. The total number of intracellular infectious virions was obtained by plaque assay
on FRT cells. Ratios reflecting relative efficiency of envelopment and infectious virion
production were obtained by dividing the average of the number of viral genomes
within the infected cells by the number of PFU.
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gate whether the engineered UL20 mutations affected interactions
between UL20p and UL37 proteins, we utilized the proximity ligation assay (42, 43) in conjunction with the anti-FLAG monoclonal antibody detecting the UL20-tagged protein and the antiUL37 polyclonal antibody. The known interaction between the
UL20 protein and gK was also tested using the anti-FLAG (UL20)
and anti-V5 (gK) antibodies, as a positive PLA control. PLA produced vivid fluorescent signals showing efficient colocalization
between the interacting gK and UL20p, as well as between UL20p
and UL37, in Vero cells infected with the parental wild-type virus
and with all mutant viruses. In contrast, mock-infected cells or
cells infected with the HSV-1(F) strain (expresses untagged gK
and UL20 proteins) did not exhibit any appreciable fluorescent
signals (Fig. 8).
DISCUSSION

We have previously shown that the gK/UL20 protein complex
serves crucial roles in cytoplasmic virion envelopment (11). Our
laboratory and others have shown that the UL37 protein localizes
to the TGN membranes and functions in cytoplasmic virion envelopment (44). Recently, we showed that the UL37 protein interacts with the gK/UL20 protein complex and facilitates cytoplasmic
virion envelopment and infectious virus production (29). Here,
we show that phenylalanine residues located at the carboxyl ter-
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Role of HSV-1 UL20 in Infectious Virus Production

FIG 7 Colocalization of UL20p and TGN in the wild-type virus and mutant
viruses. Vero cells were infected with each virus at an MOI/cell of 10, fixed at 18
h.p.i., and stained with anti-FLAG antibody for UL20p (red), TGOLN2 antibody for TGN (green), and DAPI for nucleus (blue). Scatterplot graphs, which
depict pixel intensity and distribution and an approximate percentage of subcellular colocalization, are shown for each image.
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minus of the UL20 protein are involved in the regulation of cytoplasmic virion envelopment and infectious virus production.
We have previously reported the use of extensive alanine-scanning mutagenesis of the UL20 protein to delineate domains of the
UL20 protein that function in cytoplasmic virion envelopment
and virus-induced cell fusion (30). Specifically, we showed that
the amino terminus of the UL20 protein functioned in virus-induced cell fusion, while the carboxyl terminus was important for
cytoplasmic virion envelopment (30). Of specific interest to the
current study was that deletion of the terminal six amino acids of
the UL20 protein drastically inhibited cytoplasmic virion envelopment, while it did not affect UL20 protein interactions with gK
and virus-induced cell fusion (30). Based on our recent findings
that the gK/UL20 protein complex interacts with the UL37 protein, we hypothesized that this interaction may occur between the
carboxyl terminus of the UL20 protein and the UL37 protein.
These interactions may involve phenylalanine residues, which
are known to facilitate protein-protein interactions through
residue stacking and hydrophobic interactions. Significantly, the
UL20F210A mutant caused more than 1-log-higher replication
kinetics and final infectious virus production than the parental
wild-type virus on Vero cells at a high MOI/cell. Moreover, the
ratio of total viral genomes to PFU was lower than that of the
parental wild-type virus, indicating that this mutation increases
the efficiency of infectious virus production. The observed increase in the production of infectious virions reflects enhanced
cytoplasmic virion envelopment, since it is unlikely that UL20
mutations would affect other aspects of virion assembly, such as
capsid assembly in the nucleus. Moreover, the UL20F210A mutant virus produced higher infectious virus titers at a high versus a
low MOI/cell compared to the parental wild-type virus, suggesting
that enhancement in infectious virus production is dependent on
the level of expression of the UL20F210A protein.
The UL20F210A gain-of-function mutation reveals that the
phenylalanine residue at position 210 is involved in the regulation
of cytoplasmic virion envelopment and infectious virus production. The purpose of this inhibitory mechanism is not immediately apparent. Infectious virus titers and particle-to-PFU ratios
are affected by temperature, with optimum virus titers and particle-to-PFU ratios produced at 34°C, presumably because the entire process of virion assembly is more efficient at a reduced assembly speed (K. G. Kousoulas, unpublished observations). Thus,
it is possible that the process of cytoplasmic virion envelopment is
downregulated by UL20/gK to ensure efficient virion envelopment at 37°C or higher. Alternatively, the replacement of the phenylalanine at position 210 may cause more efficient interaction of
UL20p with other viral proteins or cellular proteins involved in
cytoplasmic virion envelopment.
The UL20F222A mutant virus caused extensive virus-induced
cell fusion on Vero cells, which was completely inhibited on the
UL20-complementing FRT cells. This result suggests that the phenylalanine residue at amino acid position 222 is involved in the
regulation of membrane fusion, presumably because it alters the
interactions of the gK/UL20 protein complex with the fusogenic
glycoprotein gB. All mutant viruses produced similar plaques with
respect to size and fusogenic characteristics on FRT cells, indicating that wild-type UL20p expression by FRT cells efficiently reverted all mutant phenotypes to that of the parental wild type.
Overall, these results suggest that the wild-type UL20p expressed
by the FRT cells acts in a dominant manner to reverse the effects of
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FIG 8 Proximity ligation assay to determine UL20p and UL37 interactions. Vero cells were infected with viruses at a high MOI/cell of 10, and PLA was performed
at 18 h.p.i. (a to i) Negative-control mock infection (a), negative control with HSV-1(F) strain infection (b), positive control showing gK-UL20p interaction (c),
wild type (d), UL20⌬6 (e), UL20⌬Phe (f), UL20F222A (g), UL20F210A (h), and UL20F205-206A (i). DAPI-stained nuclei are shown in blue, and PLA-positive
signals generated by the Texas Red dye are shown in red.

these UL20 mutations, presumably because it interacts more efficiently with gK, gB, and UL37. The reversion of the phenotypic and
growth properties of the UL20 mutant viruses indicates the absence
of any other spurious mutations within the mutant viral genomes.
This conclusion is further supported by PCR-assisted sequencing of
targeted genomic areas and sequencing of the parental wild-type and
the UL20F201A genomes by next-generation sequencing methodologies, which did not detect any spurious mutations.
Phenylalanine replacement or deletion of carboxyl-terminal
regions of the UL20 protein that contained phenylalanine residues
caused drastic defects in virion envelopment without affecting
colocalization of the UL20 mutant proteins with the UL37 protein, as evidenced by similar PLA-produced fluorescent signals. Of
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particular interest is the mutagenesis of two membrane-proximal
phenylalanine residues to alanines. This double amino acid replacement was predicted to cause retraction of the carboxyl terminus of the UL20 protein so that it would no longer be exposed
to intracellular spaces (Fig. 9). The results suggest that the carboxyl terminus of the UL20 protein is not a major contributor to
overall interactions with the UL37 protein. Alternatively, mutagenesis of the carboxyl terminus of the UL20 protein may negatively affect other functional aspects of the overall interactions of
the gK/UL20 complex, as well as its potential domain-specific affinity to UL37 or other tegument proteins, causing inhibition or
enhancement of cytoplasmic virion envelopment and infectious
virus production.
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Cytoplasmic virion envelopment has been thought to involve a
series of complex interactions between viral glycoproteins embedded in the TGN membranes and tegument proteins found on
cytoplasmic capsids or bound to TGN membranes. The results
presented here show that cytoplasmic virion envelopment is a
dynamic process where interactions can affect cytoplasmic virion
envelopment in either a positive or negative manner. These dynamic interactions may provide an advantage for virus replication
in certain cells, where the virus may need to control the rate of
infectious virus production. The UL20F210A gain-of-function
mutation can be incorporated into other mutant herpesviruses
engineered for anticancer or gene therapy purposes to enhance
their beneficial functions or to alleviate their defects in replication
efficiencies and produce higher titers of virus. Further studies are
required to explore this gain-of-function behavior of the mutant
virus and to investigate whether the mutation has any effect on the
pathogenesis of the virus in experimental animal infections.
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FIG 9 SOSUI program-predicted structures of the wild-type virus and UL20⌬6
and UL20F205-206A mutants. The protein sequences of the viruses were submitted to the SOSUI program, and the predicted structures are shown.
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